IRIS
CIABATTINI, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.422
EU - Europa 5.238
AS - Asia 2.904
SA - Sud America 505
AF - Africa 166
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.244
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.315
RU - Federazione Russa 1.240
IT - Italia 982
SG - Singapore 917
CN - Cina 899
GB - Regno Unito 712
IE - Irlanda 637
BR - Brasile 409
DE - Germania 331
VN - Vietnam 326
SE - Svezia 317
FI - Finlandia 274
FR - Francia 266
HK - Hong Kong 242
UA - Ucraina 216
KR - Corea 166
IN - India 101
ZA - Sudafrica 98
CA - Canada 59
ES - Italia 47
PL - Polonia 41
BD - Bangladesh 40
NL - Olanda 36
AR - Argentina 32
IQ - Iraq 28
MX - Messico 27
UZ - Uzbekistan 24
BE - Belgio 23
JP - Giappone 20
TR - Turchia 20
AT - Austria 19
CH - Svizzera 17
VE - Venezuela 16
CZ - Repubblica Ceca 14
NG - Nigeria 14
ID - Indonesia 13
IR - Iran 13
CI - Costa d'Avorio 11
EC - Ecuador 11
GR - Grecia 10
LT - Lituania 10
SA - Arabia Saudita 10
CL - Cile 9
IL - Israele 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
JO - Giordania 7
MA - Marocco 7
PT - Portogallo 7
PY - Paraguay 7
SI - Slovenia 7
AZ - Azerbaigian 6
CO - Colombia 6
EG - Egitto 6
ET - Etiopia 6
MY - Malesia 6
PE - Perù 6
TH - Thailandia 6
AU - Australia 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
NP - Nepal 5
PH - Filippine 5
RO - Romania 5
AL - Albania 4
GE - Georgia 4
HN - Honduras 4
KZ - Kazakistan 4
TN - Tunisia 4
DK - Danimarca 3
JM - Giamaica 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
UY - Uruguay 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
MD - Moldavia 2
MT - Malta 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
ZM - Zambia 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GD - Grenada 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KY - Cayman, isole 1
Totale 14.227
Salva come PNG Salva come JPEG
Città #
Dallas 715
Dublin 636
Southend 553
Singapore 514
Fairfield 481
Ashburn 463
Chandler 332
Moscow 330
Santa Clara 287
Siena 264
Beijing 233
Hong Kong 228
San Jose 219
Woodbridge 219
Hefei 195
Jacksonville 175
Ann Arbor 161
Seattle 160
Seoul 159
Cambridge 155
Helsinki 154
Houston 153
Munich 144
Wilmington 140
Los Angeles 121
New York 103
Milan 99
Princeton 97
Johannesburg 85
Ho Chi Minh City 79
The Dalles 77
Lauterbourg 75
Rome 74
Hanoi 72
Dong Ket 68
Florence 64
Lappeenranta 64
Council Bluffs 63
Nanjing 58
São Paulo 44
Orem 40
Buffalo 33
Shanghai 33
London 32
San Mateo 32
Frankfurt am Main 28
Boardman 27
San Diego 27
Montreal 24
Brussels 23
Denver 22
Menlo Park 22
Turku 22
Bengaluru 21
Düsseldorf 21
Nuremberg 21
Shenyang 21
Tashkent 21
Chennai 20
Tokyo 20
Chicago 19
Redondo Beach 19
Warsaw 19
Lancaster 18
Málaga 16
Toronto 16
Columbus 15
Nanchang 15
Phoenix 15
San Francisco 15
Washington 15
Belo Horizonte 14
Dearborn 14
Messina 14
Atlanta 13
Fremont 13
Guangzhou 13
Piscataway 13
Haiphong 12
Hebei 12
Mumbai 12
Portsmouth 12
Abidjan 11
Abuja 11
Amsterdam 11
Kunming 11
Redwood City 11
Baghdad 10
Brooklyn 10
Changsha 10
Da Nang 10
Madrid 10
Rio de Janeiro 10
Bologna 9
Brno 9
Cape Town 9
Curitiba 9
Poggibonsi 9
Tianjin 9
Boston 8
Totale 9.324
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 355
Vaginal immunization to elicit primary T-cell activation and dissemination 329
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 303
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 300
Vaccination in the elderly: The challenge of immune changes with aging 290
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 289
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 288
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 284
Ebola vaccine R&D: Filling the knowledge gaps 279
Adoptive transfer of transgenic T cells to study mucosal adjuvants 272
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 270
Role of the microbiota in the modulation of vaccine immune responses 261
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 251
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 241
Bacillus spores for vaccine delivery 240
High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 234
Modulation of Primary Immune Response by Different Vaccine Adjuvants 231
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 230
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 223
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 216
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 208
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 206
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 204
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 202
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 200
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 200
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 194
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 194
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 191
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 190
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 187
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 186
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 186
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 185
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 183
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 181
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 179
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 175
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 175
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 175
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 174
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 173
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 173
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 172
Primary T-cell response to mucosal vaccination 171
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 171
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 170
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 169
Oral priming of mice by recombinant spores of Bacillus subtilis 168
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 164
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 164
Surface display of recombinant proteins on Bacillus subtilis spores 162
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 160
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 158
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 156
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 155
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 155
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 152
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 152
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein 149
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 144
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study 142
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 140
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 138
Primary activation of CD4+ and CD8+ T cells following mucosal vaccination with recombinant bacteria 134
Oral priming of mice using recombinant spores of Bacillus subtilis 132
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 127
Expression of immunomodulating molecules on the surface of the vaccine vector Streptococcus gordonii 125
Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers 121
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 116
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP 115
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach 113
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 112
Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2 111
null 102
Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients 98
Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniae 6
Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome 6
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV 4
Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial 4
Totale 14.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021213 0 0 0 0 0 0 0 0 0 0 96 117
2021/2022837 64 127 43 59 29 14 44 28 44 80 115 190
2022/20231.223 77 142 173 136 103 220 41 104 88 31 81 27
2023/20241.202 33 34 100 79 55 307 367 43 24 65 25 70
2024/20252.606 80 97 271 138 313 166 144 161 269 111 244 612
2025/20265.410 459 796 593 763 1.079 217 586 188 250 359 120 0
Totale 14.445